AVP‐825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial
Year: 2017
Type: article
DOI: 10.1111/head.13199
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Avanir Pharmaceuticals
OpenAlex ID: W2765275243
